Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohort Cristina Suárez Ferrer; Francisco Mesonero Gismero; Berta Caballol; Maria Pilar Ballester; Iria Bastón Rey; Andrés Castaño García; Jose Miranda Bautista; Rosa Saiz Chumillas; Jose Manuel Benitez; Laura Sanchez-Delgado; Alicia López-García; Cristina Rubin de Celix; Inmaculada Alonso Abreu; Luigi Melcarne; Rocío Plaza Santos; Miquel Marques-Camí; Antonio Caballero Mateos; César Gómez Díez; Margalida Calafat; Horacio Alonso Galan; Pablo Vega Vilaamil; Beatriz Castro Senosiain; Andrea Guerro Moya; Carmen Yolanda Rodriguez Diaz; Katerina Spicakova; Noemi Manceñido Marcos; Gema Molina; Luisa de Castro Parga; Andres Rodriguez Angulo; Lidia Cuevas del Campo; Maria del Carmen Rodriguez Grau; Fernando Ramirez; Barbara Gomez Pastrana; Irene Gonzalez Partida; Belen Botella Mateu; Elena Peña Gonzalez; Eduardo Iyo; Alfonso Elosua Gonzalez; Empar Sainz Arnau; Luis Hernandez Villalba; Pablo Perez Galindo; Leyanira Torrealba Medina; Sara Monsalve Alonso; Jose Antonio Olmos Perez; Carmen Dueñas Sadornil; Laura Garcia Ramirez; María Dolores Martín-Arranz; Antonio López Sanroman; Agnès Fernández; Victor Merino Murgui; Cristina Calviño Suárez; Pablo Flórez-Diez; María Elena Lobato Matilla; Beatriz Sicilia; Pilar Soto Escribano; Carlos Maroto Martin; Míriam Mañosa; Manuel Barreiro-De Acosta;

Optimizing outcomes with maintenance IV UST in highly bio-exposed patients with IBD. Efficacy and Adjusted Regimen in Real World A. Mínguez; E. Coello; A. Garrido; P. Ripoll; M. Gomez; M. Aguas; M. Iborra; E. Cerrillo; L. Tortosa; V. Bayarri; N. Bueno; MJ Fernández; R. Marqués; P. Nos; G. Bastida;

Selective granulocyte¿monocyte apheresis during induction with vedolizumab in moderate¿severe ulcerative colitis: Experience in a tertiary hospital Cristina Suárez Ferrer; Eduardo Martin-Arranz; María Dolores Martín-Arranz;